The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Combined Hormonal Contraceptives Market Research Report 2025
Synopsis
Combined hormonal contraceptives are used to prevent pregnancies. They are also used in the treatment of acne vulgaris, endometriosis, polycystic ovarian syndrome, and irregular menstrual flow by blocking ovulation. These products are widely used by women of aged between 15 and 49 years.
The global Combined Hormonal Contraceptives market was valued at US$ 17780 million in 2023 and is anticipated to reach US$ 22360 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Combined Hormonal Contraceptives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Combined Hormonal Contraceptives.
Report Scope
The Combined Hormonal Contraceptives market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Combined Hormonal Contraceptives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Combined Hormonal Contraceptives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Actavis
Agile Therapeutics
Allergan
Bayer
Teva Pharmaceutical Industries
ANI Pharmaceuticals
Ortho-McNeil-Janssen Pharmaceuticals
Noven Pharmaceuticals
Johnson & Johnson
Mylan
Segment by Type
15-24 years
25-34 years
35-44 years
Above 44 years
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Combined Hormonal Contraceptives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Combined Hormonal Contraceptives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Combined hormonal contraceptives are used to prevent pregnancies. They are also used in the treatment of acne vulgaris, endometriosis, polycystic ovarian syndrome, and irregular menstrual flow by blocking ovulation. These products are widely used by women of aged between 15 and 49 years.
The global Combined Hormonal Contraceptives market was valued at US$ 17780 million in 2023 and is anticipated to reach US$ 22360 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Combined Hormonal Contraceptives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Combined Hormonal Contraceptives.
Report Scope
The Combined Hormonal Contraceptives market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Combined Hormonal Contraceptives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Combined Hormonal Contraceptives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Actavis
Agile Therapeutics
Allergan
Bayer
Teva Pharmaceutical Industries
ANI Pharmaceuticals
Ortho-McNeil-Janssen Pharmaceuticals
Noven Pharmaceuticals
Johnson & Johnson
Mylan
Segment by Type
15-24 years
25-34 years
35-44 years
Above 44 years
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Combined Hormonal Contraceptives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Combined Hormonal Contraceptives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Combined Hormonal Contraceptives Market Overview
1.1 Product Overview and Scope of Combined Hormonal Contraceptives
1.2 Combined Hormonal Contraceptives Segment by Type
1.2.1 Global Combined Hormonal Contraceptives Market Value Comparison by Type (2024-2030)
1.2.2 15-24 years
1.2.3 25-34 years
1.2.4 35-44 years
1.2.5 Above 44 years
1.3 Combined Hormonal Contraceptives Segment by Application
1.3.1 Global Combined Hormonal Contraceptives Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Combined Hormonal Contraceptives Market Size Estimates and Forecasts
1.4.1 Global Combined Hormonal Contraceptives Revenue 2019-2030
1.4.2 Global Combined Hormonal Contraceptives Sales 2019-2030
1.4.3 Global Combined Hormonal Contraceptives Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Combined Hormonal Contraceptives Market Competition by Manufacturers
2.1 Global Combined Hormonal Contraceptives Sales Market Share by Manufacturers (2019-2024)
2.2 Global Combined Hormonal Contraceptives Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Combined Hormonal Contraceptives Average Price by Manufacturers (2019-2024)
2.4 Global Combined Hormonal Contraceptives Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Combined Hormonal Contraceptives, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Combined Hormonal Contraceptives, Product Type & Application
2.7 Combined Hormonal Contraceptives Market Competitive Situation and Trends
2.7.1 Combined Hormonal Contraceptives Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Combined Hormonal Contraceptives Players Market Share by Revenue
2.7.3 Global Combined Hormonal Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Combined Hormonal Contraceptives Retrospective Market Scenario by Region
3.1 Global Combined Hormonal Contraceptives Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Combined Hormonal Contraceptives Global Combined Hormonal Contraceptives Sales by Region: 2019-2030
3.2.1 Global Combined Hormonal Contraceptives Sales by Region: 2019-2024
3.2.2 Global Combined Hormonal Contraceptives Sales by Region: 2025-2030
3.3 Global Combined Hormonal Contraceptives Global Combined Hormonal Contraceptives Revenue by Region: 2019-2030
3.3.1 Global Combined Hormonal Contraceptives Revenue by Region: 2019-2024
3.3.2 Global Combined Hormonal Contraceptives Revenue by Region: 2025-2030
3.4 North America Combined Hormonal Contraceptives Market Facts & Figures by Country
3.4.1 North America Combined Hormonal Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Combined Hormonal Contraceptives Sales by Country (2019-2030)
3.4.3 North America Combined Hormonal Contraceptives Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Combined Hormonal Contraceptives Market Facts & Figures by Country
3.5.1 Europe Combined Hormonal Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Combined Hormonal Contraceptives Sales by Country (2019-2030)
3.5.3 Europe Combined Hormonal Contraceptives Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Combined Hormonal Contraceptives Market Facts & Figures by Country
3.6.1 Asia Pacific Combined Hormonal Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Combined Hormonal Contraceptives Sales by Country (2019-2030)
3.6.3 Asia Pacific Combined Hormonal Contraceptives Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Combined Hormonal Contraceptives Market Facts & Figures by Country
3.7.1 Latin America Combined Hormonal Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Combined Hormonal Contraceptives Sales by Country (2019-2030)
3.7.3 Latin America Combined Hormonal Contraceptives Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Combined Hormonal Contraceptives Market Facts & Figures by Country
3.8.1 Middle East and Africa Combined Hormonal Contraceptives Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Combined Hormonal Contraceptives Sales by Country (2019-2030)
3.8.3 Middle East and Africa Combined Hormonal Contraceptives Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Combined Hormonal Contraceptives Sales by Type (2019-2030)
4.1.1 Global Combined Hormonal Contraceptives Sales by Type (2019-2024)
4.1.2 Global Combined Hormonal Contraceptives Sales by Type (2025-2030)
4.1.3 Global Combined Hormonal Contraceptives Sales Market Share by Type (2019-2030)
4.2 Global Combined Hormonal Contraceptives Revenue by Type (2019-2030)
4.2.1 Global Combined Hormonal Contraceptives Revenue by Type (2019-2024)
4.2.2 Global Combined Hormonal Contraceptives Revenue by Type (2025-2030)
4.2.3 Global Combined Hormonal Contraceptives Revenue Market Share by Type (2019-2030)
4.3 Global Combined Hormonal Contraceptives Price by Type (2019-2030)
5 Segment by Application
5.1 Global Combined Hormonal Contraceptives Sales by Application (2019-2030)
5.1.1 Global Combined Hormonal Contraceptives Sales by Application (2019-2024)
5.1.2 Global Combined Hormonal Contraceptives Sales by Application (2025-2030)
5.1.3 Global Combined Hormonal Contraceptives Sales Market Share by Application (2019-2030)
5.2 Global Combined Hormonal Contraceptives Revenue by Application (2019-2030)
5.2.1 Global Combined Hormonal Contraceptives Revenue by Application (2019-2024)
5.2.2 Global Combined Hormonal Contraceptives Revenue by Application (2025-2030)
5.2.3 Global Combined Hormonal Contraceptives Revenue Market Share by Application (2019-2030)
5.3 Global Combined Hormonal Contraceptives Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Actavis
6.1.1 Actavis Corporation Information
6.1.2 Actavis Description and Business Overview
6.1.3 Actavis Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Actavis Combined Hormonal Contraceptives Product Portfolio
6.1.5 Actavis Recent Developments/Updates
6.2 Agile Therapeutics
6.2.1 Agile Therapeutics Corporation Information
6.2.2 Agile Therapeutics Description and Business Overview
6.2.3 Agile Therapeutics Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Agile Therapeutics Combined Hormonal Contraceptives Product Portfolio
6.2.5 Agile Therapeutics Recent Developments/Updates
6.3 Allergan
6.3.1 Allergan Corporation Information
6.3.2 Allergan Description and Business Overview
6.3.3 Allergan Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Allergan Combined Hormonal Contraceptives Product Portfolio
6.3.5 Allergan Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer Combined Hormonal Contraceptives Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Teva Pharmaceutical Industries
6.5.1 Teva Pharmaceutical Industries Corporation Information
6.5.2 Teva Pharmaceutical Industries Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Pharmaceutical Industries Combined Hormonal Contraceptives Product Portfolio
6.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.6 ANI Pharmaceuticals
6.6.1 ANI Pharmaceuticals Corporation Information
6.6.2 ANI Pharmaceuticals Description and Business Overview
6.6.3 ANI Pharmaceuticals Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ANI Pharmaceuticals Combined Hormonal Contraceptives Product Portfolio
6.6.5 ANI Pharmaceuticals Recent Developments/Updates
6.7 Ortho-McNeil-Janssen Pharmaceuticals
6.6.1 Ortho-McNeil-Janssen Pharmaceuticals Corporation Information
6.6.2 Ortho-McNeil-Janssen Pharmaceuticals Description and Business Overview
6.6.3 Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Product Portfolio
6.7.5 Ortho-McNeil-Janssen Pharmaceuticals Recent Developments/Updates
6.8 Noven Pharmaceuticals
6.8.1 Noven Pharmaceuticals Corporation Information
6.8.2 Noven Pharmaceuticals Description and Business Overview
6.8.3 Noven Pharmaceuticals Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Noven Pharmaceuticals Combined Hormonal Contraceptives Product Portfolio
6.8.5 Noven Pharmaceuticals Recent Developments/Updates
6.9 Johnson & Johnson
6.9.1 Johnson & Johnson Corporation Information
6.9.2 Johnson & Johnson Description and Business Overview
6.9.3 Johnson & Johnson Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Johnson & Johnson Combined Hormonal Contraceptives Product Portfolio
6.9.5 Johnson & Johnson Recent Developments/Updates
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Description and Business Overview
6.10.3 Mylan Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Mylan Combined Hormonal Contraceptives Product Portfolio
6.10.5 Mylan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Combined Hormonal Contraceptives Industry Chain Analysis
7.2 Combined Hormonal Contraceptives Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Combined Hormonal Contraceptives Production Mode & Process
7.4 Combined Hormonal Contraceptives Sales and Marketing
7.4.1 Combined Hormonal Contraceptives Sales Channels
7.4.2 Combined Hormonal Contraceptives Distributors
7.5 Combined Hormonal Contraceptives Customers
8 Combined Hormonal Contraceptives Market Dynamics
8.1 Combined Hormonal Contraceptives Industry Trends
8.2 Combined Hormonal Contraceptives Market Drivers
8.3 Combined Hormonal Contraceptives Market Challenges
8.4 Combined Hormonal Contraceptives Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
